ArticleACS medicinal chemistry letters2026
The Potential of DNA Polymerase Theta (POLQ) Inhibitors as Cancer Therapy for Homologous Recombination (HR)-Deficient Tumors.
Ahmed F Abdel-MagidPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.